Company news
Gyre Therapeutics, Inc. news in 2019
Gyre Therapeutics, Inc.'s news releases, calls and decks from 2019, newest first.
Catalyst Biosciences Announces Global License and Collaboration Agreement to Develop Pegylated CB 2782 for the Treatment of Dry Age-Related Macular Degeneration
December 18, 2019
Catalyst Biosciences Presents Two Posters on MarzAA at the 61st Annual American Society of Hematology Conference
December 8, 2019
Catalyst Biosciences to Present at the Stifel Healthcare Conference
November 11, 2019
Catalyst Biosciences Reports Third Quarter 2019 Operating & Financial Results and Provides a Corporate Update
November 6, 2019
Catalyst Biosciences Announces Poster Presentations at the 61st Annual American Society of Hematology Conference
November 5, 2019
Catalyst Biosciences Provides DalcA Phase 2b Trial Update
October 2, 2019